The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cerebral Embolic Protection Devices for TAVI Market Research Report 2025
Synopsis
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
The global Cerebral Embolic Protection Devices for TAVI market was valued at US$ 52 million in 2023 and is anticipated to reach US$ 257.7 million by 2030, witnessing a CAGR of 25.9% during the forecast period 2024-2030.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.
Report Scope
The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cerebral Embolic Protection Devices for TAVI market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cerebral Embolic Protection Devices for TAVI manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline
Segment by Type
Total Artery Coverage
Non-total Artery Coverage
Segment by Application
Hopsital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
The global Cerebral Embolic Protection Devices for TAVI market was valued at US$ 52 million in 2023 and is anticipated to reach US$ 257.7 million by 2030, witnessing a CAGR of 25.9% during the forecast period 2024-2030.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.
Report Scope
The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cerebral Embolic Protection Devices for TAVI market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cerebral Embolic Protection Devices for TAVI manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline
Segment by Type
Total Artery Coverage
Non-total Artery Coverage
Segment by Application
Hopsital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cerebral Embolic Protection Devices for TAVI Market Overview
1.1 Product Overview and Scope of Cerebral Embolic Protection Devices for TAVI
1.2 Cerebral Embolic Protection Devices for TAVI Segment by Type
1.2.1 Global Cerebral Embolic Protection Devices for TAVI Market Value Comparison by Type (2024-2030)
1.2.2 Total Artery Coverage
1.2.3 Non-total Artery Coverage
1.3 Cerebral Embolic Protection Devices for TAVI Segment by Application
1.3.1 Global Cerebral Embolic Protection Devices for TAVI Market Value by Application: (2024-2030)
1.3.2 Hopsital
1.3.3 Others
1.4 Global Cerebral Embolic Protection Devices for TAVI Market Size Estimates and Forecasts
1.4.1 Global Cerebral Embolic Protection Devices for TAVI Revenue 2019-2030
1.4.2 Global Cerebral Embolic Protection Devices for TAVI Sales 2019-2030
1.4.3 Global Cerebral Embolic Protection Devices for TAVI Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cerebral Embolic Protection Devices for TAVI Market Competition by Manufacturers
2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Manufacturers (2019-2024)
2.4 Global Cerebral Embolic Protection Devices for TAVI Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Product Type & Application
2.7 Cerebral Embolic Protection Devices for TAVI Market Competitive Situation and Trends
2.7.1 Cerebral Embolic Protection Devices for TAVI Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cerebral Embolic Protection Devices for TAVI Players Market Share by Revenue
2.7.3 Global Cerebral Embolic Protection Devices for TAVI Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cerebral Embolic Protection Devices for TAVI Retrospective Market Scenario by Region
3.1 Global Cerebral Embolic Protection Devices for TAVI Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cerebral Embolic Protection Devices for TAVI Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2019-2030
3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2019-2024
3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2025-2030
3.3 Global Cerebral Embolic Protection Devices for TAVI Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2019-2030
3.3.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2019-2024
3.3.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2025-2030
3.4 North America Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.4.1 North America Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales by Country (2019-2030)
3.4.3 North America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.5.1 Europe Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales by Country (2019-2030)
3.5.3 Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales by Country (2019-2030)
3.6.3 Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.7.1 Latin America Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cerebral Embolic Protection Devices for TAVI Sales by Country (2019-2030)
3.7.3 Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.8.1 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2019-2030)
4.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2019-2024)
4.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2025-2030)
4.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Type (2019-2030)
4.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2019-2030)
4.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2019-2024)
4.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2025-2030)
4.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Type (2019-2030)
4.3 Global Cerebral Embolic Protection Devices for TAVI Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2019-2030)
5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2019-2024)
5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2025-2030)
5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Application (2019-2030)
5.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2019-2030)
5.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2019-2024)
5.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2025-2030)
5.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Application (2019-2030)
5.3 Global Cerebral Embolic Protection Devices for TAVI Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific (Claret Medical)
6.1.1 Boston Scientific (Claret Medical) Corporation Information
6.1.2 Boston Scientific (Claret Medical) Description and Business Overview
6.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.1.5 Boston Scientific (Claret Medical) Recent Developments/Updates
6.2 Venus Medtech (Keystone Heart)
6.2.1 Venus Medtech (Keystone Heart) Corporation Information
6.2.2 Venus Medtech (Keystone Heart) Description and Business Overview
6.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.2.5 Venus Medtech (Keystone Heart) Recent Developments/Updates
6.3 Transverse Medical
6.3.1 Transverse Medical Corporation Information
6.3.2 Transverse Medical Description and Business Overview
6.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.3.5 Transverse Medical Recent Developments/Updates
6.4 Innovative Cardiovascular Solutions
6.4.1 Innovative Cardiovascular Solutions Corporation Information
6.4.2 Innovative Cardiovascular Solutions Description and Business Overview
6.4.3 Innovative Cardiovascular Solutions Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Innovative Cardiovascular Solutions Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.4.5 Innovative Cardiovascular Solutions Recent Developments/Updates
6.5 Protembis GmbH
6.5.1 Protembis GmbH Corporation Information
6.5.2 Protembis GmbH Description and Business Overview
6.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.5.5 Protembis GmbH Recent Developments/Updates
6.6 Filterlex Medical
6.6.1 Filterlex Medical Corporation Information
6.6.2 Filterlex Medical Description and Business Overview
6.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.6.5 Filterlex Medical Recent Developments/Updates
6.7 Emboline
6.6.1 Emboline Corporation Information
6.6.2 Emboline Description and Business Overview
6.6.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.7.5 Emboline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cerebral Embolic Protection Devices for TAVI Industry Chain Analysis
7.2 Cerebral Embolic Protection Devices for TAVI Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cerebral Embolic Protection Devices for TAVI Production Mode & Process
7.4 Cerebral Embolic Protection Devices for TAVI Sales and Marketing
7.4.1 Cerebral Embolic Protection Devices for TAVI Sales Channels
7.4.2 Cerebral Embolic Protection Devices for TAVI Distributors
7.5 Cerebral Embolic Protection Devices for TAVI Customers
8 Cerebral Embolic Protection Devices for TAVI Market Dynamics
8.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
8.2 Cerebral Embolic Protection Devices for TAVI Market Drivers
8.3 Cerebral Embolic Protection Devices for TAVI Market Challenges
8.4 Cerebral Embolic Protection Devices for TAVI Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
